Novartis AG Free Cash Flow 2010-2024 | NVS

Novartis AG free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Novartis AG annual free cash flow for 2023 was $13.635B, a 1.16% increase from 2022.
  • Novartis AG annual free cash flow for 2022 was $13.478B, a 3.27% decline from 2021.
  • Novartis AG annual free cash flow for 2021 was $13.933B, a 11.79% increase from 2020.

Novartis AG Free Cash Flow 2010-2024 | NVS

  • Novartis AG annual free cash flow for 2023 was $13.635B, a 1.16% increase from 2022.
  • Novartis AG annual free cash flow for 2022 was $13.478B, a 3.27% decline from 2021.
  • Novartis AG annual free cash flow for 2021 was $13.933B, a 11.79% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$763.3B
Novo Nordisk (NVO)$377.1B
Johnson & Johnson (JNJ)$363.9B
AbbVie (ABBV)$309.7B
Merck (MRK)$248.6B
Roche Holding AG (RHHBY)$247.8B
AstraZeneca (AZN)$217.9B
Pfizer (PFE)$150.9B
Sanofi (SNY)$132.3B
Bayer (BAYRY)$22.2B
Innoviva (INVA)$1.2B